Colyer Alice, Wolf Esther, Lento Cristina, Ustav Mart, Sljoka Adnan, Wilson Derek J
Department of Chemistry, York University, Toronto M3J 1P3, Canada.
Icosagen Cell Factory OÜ, Tartu, Estonia.
J Mol Biol. 2025 Sep 1;437(17):169232. doi: 10.1016/j.jmb.2025.169232. Epub 2025 May 28.
The SARS-CoV-2 spike protein is highly antigenic, with epitopes in three distinct regions of the receptor binding domain (RBD) alone that have known mechanisms of neutralization. In previous work, we predicted a fourth RBD epitope based on allosteric conformational perturbations measured by hydrogen-deuterium exchange mass spectrometry (HDX-MS) upon complexation with the canonical spike protein target, human angiotensin-converting enzyme 2 (hACE2). We subsequently identified a pan-neutralizing antibody (ICO-hu104) with the predicted epitope, however, as the epitope was somewhat distant from the hACE2 binding interface, and our previous work limited to the spike RBD, the neutralization mechanism was unclear. Using HDX-MS, we investigated the binding of ICO-hu104 to the full-length SARS-CoV-2 spike protein from Wuhan, Delta and Omicron variants. We demonstrate that binding of ICO-hu104 results in an increase in deuterium uptake in the distant HR1 domain in latter variants, which in a biological context could be indicative of destabilisation of the helices within this region, promoting premature S1 shedding or failure of helical extension during S2-mediated fusion. This is supported by our computational modelling, highlighting propagation of allosteric effects to the S2 coiled-coil region upon rigidification of the ICO-hu104 epitope. Collectively, this work demonstrates an alternative neutralization mechanism for ICO-hu104 which is distinct from its first-generation predecessors and thus opens alternative avenues targeting non-RBD epitopes through allosteric perturbations.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白具有高度抗原性,仅受体结合域(RBD)的三个不同区域就有已知的中和机制的表位。在之前的工作中,我们基于与典型刺突蛋白靶点人血管紧张素转换酶2(hACE2)结合时通过氢-氘交换质谱(HDX-MS)测量的变构构象扰动,预测了第四个RBD表位。随后,我们鉴定出一种具有预测表位的泛中和抗体(ICO-hu104),然而,由于该表位与hACE2结合界面有些距离,且我们之前的工作仅限于刺突RBD,其中和机制尚不清楚。我们使用HDX-MS研究了ICO-hu104与来自武汉、德尔塔和奥密克戎变体的全长SARS-CoV-2刺突蛋白的结合。我们证明,ICO-hu104的结合导致后一种变体中远距离HR1结构域的氘摄取增加,在生物学背景下,这可能表明该区域内螺旋的不稳定,促进过早的S1脱落或S2介导融合过程中螺旋延伸的失败。这得到了我们的计算模型的支持,突出了在ICO-hu104表位刚性化后变构效应向S2卷曲螺旋区域的传播。总的来说,这项工作证明了ICO-hu104的一种不同于其第一代前身的替代中和机制,从而开辟了通过变构扰动靶向非RBD表位的替代途径。